BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36440797)

  • 21. Melanoma nodal management in Ontario the year after the 2012 American Society of Clinical Oncology and Society of Surgical Oncology guideline.
    Latosinsky S; Allen B; Shariff SZ
    Curr Oncol; 2019 Oct; 26(5):330-337. PubMed ID: 31708651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma.
    de Vries M; Hoekstra HJ; Hoekstra-Weebers JE
    Ann Surg Oncol; 2009 Oct; 16(10):2840-7. PubMed ID: 19639366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
    Blankenstein SA; Bonenkamp JJ; Aarts MJB; van den Berkmortel FWPJ; Blank CU; Blokx WAM; Boers-Sonderen MJ; van den Eertwegh AJM; Franken MG; de Groot JWB; Haanen JBAG; Hospers GAP; Kapiteijn EW; van Not OJ; Piersma D; van Rijn RS; Suijkerbuijk KPM; van der Veldt AAM; Vreugdenhil G; Westgeest HM; Wouters MWJM; van Akkooi ACJ
    Ann Surg Oncol; 2023 Jan; 30(1):573-586. PubMed ID: 36203067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphatic flow is mostly preserved after sentinel lymph node biopsy in primary cutaneous malignant melanoma.
    Yokota K; Sawada M; Matsumoto T; Hasegawa Y; Kono M; Akiyama M
    J Dermatol Sci; 2015 May; 78(2):101-7. PubMed ID: 25771166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wide local excision prior to sentinel lymph node biopsy for primary melanoma of the head and neck.
    May MM; Lohse CM; Moore EJ; Price DL; Van Abel KM; Brewer JD; Janus JR
    Int J Dermatol; 2019 Oct; 58(10):1184-1190. PubMed ID: 30968948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Twelve years' experience of sentinel lymph node biopsy for melanoma at a rural New Zealand hospital.
    Sakowska MM; Smith N; Coutts RJ
    N Z Med J; 2014 Jun; 127(1395):12-22. PubMed ID: 24929689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma.
    Erman AB; Collar RM; Griffith KA; Lowe L; Sabel MS; Bichakjian CK; Wong SL; McLean SA; Rees RS; Johnson TM; Bradford CR
    Cancer; 2012 Feb; 118(4):1040-7. PubMed ID: 21773971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
    Hieken TJ; Grotz TE; Comfere NI; Inselman JW; Habermann EB
    Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evaluation of the clinicopathologic and gene expression profile (CP-GEP) in patients with melanoma eligible for sentinel lymph node biopsy: A multicenter prospective Dutch study.
    Stassen RC; Mulder EEAP; Mooyaart AL; Francken AB; van der Hage J; Aarts MJB; van der Veldt AAM; Verhoef C; Grünhagen DJ
    Eur J Surg Oncol; 2023 Dec; 49(12):107249. PubMed ID: 37907016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck.
    Fritsch VA; Cunningham JE; Lentsch EJ
    Otolaryngol Head Neck Surg; 2016 Jan; 154(1):94-103. PubMed ID: 26399717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymph node biopsy in melanoma: final results of MSLT-I.
    Durham AB; Wong SL
    Future Oncol; 2014 May; 10(7):1121-3. PubMed ID: 24947251
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Li N; Zhou X; Zhu H; Wang F; Guo R; Zhang Y; Song Y; Zhai S; Xie Q; Liu J; Li Z; Yang Z
    Ann Nucl Med; 2023 Mar; 37(3):189-197. PubMed ID: 36586034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natural history of thin melanoma and the utility of sentinel lymph node biopsy.
    Durham AB; Schwartz JL; Lowe L; Zhao L; Johnson AG; Harms KL; Bichakjian CK; Orsini AP; McLean SA; Bradford CR; Cohen MS; Johnson TM; Sabel MS; Wong SL
    J Surg Oncol; 2017 Dec; 116(8):1185-1192. PubMed ID: 28715140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Research progress of sentinel lymph node biopsy and regional dissection in melanoma].
    Liu WF; Yang FJ; Niu XH
    Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):481-485. PubMed ID: 31357833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement and persistent disparities in completion lymph node dissection: Lessons from the National Cancer Database.
    Chu BS; Koffi W; Hoehn RS; Ertel A; Shah SA; Ahmad SA; Sussman JJ; Neuman HB; Abbott DE
    J Surg Oncol; 2017 Dec; 116(8):1176-1184. PubMed ID: 28743173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Cutaneous Melanoma of the Head and Neck With Wide Local Excision Versus Mohs.
    Namin AW; Oudin EM; Tassone PT; Galloway TLI; Dooley LM; Zitsch RP
    Laryngoscope; 2021 Nov; 131(11):2490-2496. PubMed ID: 33844289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel lymph node biopsy for melanoma: indications and rationale.
    Phan GQ; Messina JL; Sondak VK; Zager JS
    Cancer Control; 2009 Jul; 16(3):234-9. PubMed ID: 19556963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of repeat sentinel lymph node biopsy in patients who develop recurrent melanoma.
    Beasley GM; Speicher P; Sharma K; Seigler H; Salama A; Mosca P; Tyler DS
    J Am Coll Surg; 2014 Apr; 218(4):686-92. PubMed ID: 24529806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does the time interval between sentinel lymph node biopsy and completion lymph node dissection affect outcome in malignant melanoma? A retrospective cohort study.
    Richtig G; Richtig E; Neiss AN; Quehenberger F; Gmainer DG; Kamolz LP; Lumenta DB
    Int J Surg; 2020 Mar; 75():160-164. PubMed ID: 32036082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma.
    Thomas JM; Clark MA
    Eur J Surg Oncol; 2004 Aug; 30(6):686-91. PubMed ID: 15256245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.